Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Sclerosis and CTSS[original query] |
---|
Pharmacogenomics of responsiveness to interferon IFN-beta treatment in multiple sclerosis: a genetic screen of 100 type I interferon-inducible genes. Clinical pharmacology and therapeutics 2005 Dec 78 (6): 635-46. Cunningham Stephen, Graham Colin, Hutchinson Michael, Droogan Aidan, O'Rourke Killian, Patterson Chris, McDonnell Gavin, Hawkins Stanley, Vandenbroeck Ko |
Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers. Pharmacogenetics and genomics 2007 Aug 17 (8): 657-66. Grossman Iris, Avidan Nili, Singer Clara, Goldstaub Dan, Hayardeny Liat, Eyal Eli, Ben-Asher Edna, Paperna Tamar, Pe'er Itsik, Lancet Doron, Beckmann Jacques S, Miller Ari |
Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis. Molecular neurobiology 2021 Jun . Carrasco-Campos María Isabel, Pérez-Ramírez Cristina, Macías-Cortés Elena, Puerta-García Elena, Sánchez-Pozo Antonio, Arnal-García Carmen, Barrero-Hernández Francisco Javier, Calleja-Hernández Miguel Ángel, Jiménez-Morales Alberto, Cañadas-Garre Mari |
Combined epigenetic/genetic study identified an ALS age of onset modifier. Acta neuropathologica communications 2021 4 9 (1): 75. Zhang Ming, Xi Zhengrui, Saez-Atienzar Sara, Chia Ruth, Moreno Danielle, Sato Christine, Montazer Haghighi Mahdi, Traynor Bryan J, Zinman Lorne, Rogaeva Ekateri |
Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients. Journal of personalized medicine 2021 Oct 11 (10): . Zarzuelo-Romero María José, Pérez-Ramírez Cristina, Cura Yasmín, Carrasco-Campos María Isabel, Marangoni-Iglecias Luciana María, Ramírez-Tortosa María Carmen, Jiménez-Morales Alber |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: